Skip to main content
. 2020 Feb 6;111(2):571–579. doi: 10.1111/cas.14265

Figure 3.

Figure 3

Computed tomography images showing antitumor activity of E7090. A, Baseline. B, Cycle 3, day 1 in the patient who achieved a partial response. The target lesion (para‐aortic lymphadenopathy) was reduced by 71% (from 38 to 11 mm). Arrows show the target lesion